Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Activity Chemical information
Sel. page Common
name
GPCRdb
ID
Reference
ligand
Vendors

Species

Assay
Type

Activity
Type
Activity
Relation
Activity
Value
p-value
(-log)
Fold
selectivity
Tested
GPCRs
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

1499 2091 None 34 Human Functional pEC50 = 8.3 8.3 -63 38
Agonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
3779 2091 None 34 Human Functional pEC50 = 8.3 8.3 -63 38
Agonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
3779.0 2091 None 34 Human Functional pEC50 = 8.3 8.3 -63 38
Agonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
536 2091 None 34 Human Functional pEC50 = 8.3 8.3 -63 38
Agonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
CHEMBL434 2091 None 34 Human Functional pEC50 = 8.3 8.3 -63 38
Agonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
DB01064 2091 None 34 Human Functional pEC50 = 8.3 8.3 -63 38
Agonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
1499 2091 None 34 Human Functional pEC50 = 8.1 8.1 -63 38
Agonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
3779 2091 None 34 Human Functional pEC50 = 8.1 8.1 -63 38
Agonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
3779.0 2091 None 34 Human Functional pEC50 = 8.1 8.1 -63 38
Agonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
536 2091 None 34 Human Functional pEC50 = 8.1 8.1 -63 38
Agonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
CHEMBL434 2091 None 34 Human Functional pEC50 = 8.1 8.1 -63 38
Agonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
DB01064 2091 None 34 Human Functional pEC50 = 8.1 8.1 -63 38
Agonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
12460 253 None 0 Human Functional pEC50 = 2.5 2.5 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 163 0 1 4 -0.7 CC1=CC(=O)NS(=O)(=O)O1 15537898
36573 253 None 0 Human Functional pEC50 = 2.5 2.5 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 163 0 1 4 -0.7 CC1=CC(=O)NS(=O)(=O)O1 15537898
CHEMBL176687 253 None 0 Human Functional pEC50 = 2.5 2.5 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 163 0 1 4 -0.7 CC1=CC(=O)NS(=O)(=O)O1 15537898
5143 3457 None 0 Human Functional pEC50 = 2.8 2.8 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 183 0 1 3 0.1 O=C1NS(=O)(=O)c2c1cccc2 15537898
5432 3457 None 0 Human Functional pEC50 = 2.8 2.8 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 183 0 1 3 0.1 O=C1NS(=O)(=O)c2c1cccc2 15537898
CHEMBL310671 3457 None 0 Human Functional pEC50 = 2.8 2.8 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 183 0 1 3 0.1 O=C1NS(=O)(=O)c2c1cccc2 15537898
115149 390 None 0 Human Functional pEC50 = 4.1 4.1 -186 3
UnclassifiedUnclassified
Guide to Pharmacology 586 7 6 13 1.1 C=C[C@@H]1[C@@H]2CCOC(=O)C2=CO[C@H]1O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)OC(=O)C4=C(C=C(C=C4O)O)C5=CC(=CC=C5)O 20022913
12459 390 None 0 Human Functional pEC50 = 4.1 4.1 -186 3
UnclassifiedUnclassified
Guide to Pharmacology 586 7 6 13 1.1 C=C[C@@H]1[C@@H]2CCOC(=O)C2=CO[C@H]1O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)OC(=O)C4=C(C=C(C=C4O)O)C5=CC(=CC=C5)O 20022913
12468 1864 None 0 Human Functional pEC50 = 5.2 5.2 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 262 0 1 4 1.2 C[C@H]1[C@H]2[C@@H](CC1=O)C(=C)C[C@@H]([C@@H]3[C@@H]2OC(=O)C3=C)O 26406243
442256 1864 None 0 Human Functional pEC50 = 5.2 5.2 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 262 0 1 4 1.2 C[C@H]1[C@H]2[C@@H](CC1=O)C(=C)C[C@@H]([C@@H]3[C@@H]2OC(=O)C3=C)O 26406243
CHEMBL271958 1864 None 0 Human Functional pEC50 = 5.2 5.2 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 262 0 1 4 1.2 C[C@H]1[C@H]2[C@@H](CC1=O)C(=C)C[C@@H]([C@@H]3[C@@H]2OC(=O)C3=C)O 26406243
102129367 595 None 0 Human Functional pEC50 = 5.4 5.4 3 2
UnclassifiedUnclassified
Guide to Pharmacology 330 1 1 4 2.6 C[C@@]12CC(=O)C3=C([C@H]1CC[C@]45[C@H]2[C@@H]6C[C@H](C4)[C@@](C5)(O6)CO)CCO3 32437139
12469 595 None 0 Human Functional pEC50 = 5.4 5.4 3 2
UnclassifiedUnclassified
Guide to Pharmacology 330 1 1 4 2.6 C[C@@]12CC(=O)C3=C([C@H]1CC[C@]45[C@H]2[C@@H]6C[C@H](C4)[C@@](C5)(O6)CO)CCO3 32437139
12467 1284 None 0 Human Functional pEC50 = 5.5 5.5 - 1
UnclassifiedUnclassified
Guide to Pharmacology None None None None 35364812
12498 354 None 0 Human Functional pEC50 = 5.9 5.9 - 1
UnclassifiedUnclassified
Guide to Pharmacology 418 3 7 9 -0.9 C1=CC2=C(C(=C1)O)C(=O)C3=C(C2[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C=C(C=C3O)CO 17702579
9866696 354 None 0 Human Functional pEC50 = 5.9 5.9 - 1
UnclassifiedUnclassified
Guide to Pharmacology 418 3 7 9 -0.9 C1=CC2=C(C(=C1)O)C(=O)C3=C(C2[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C=C(C=C3O)CO 17702579
CHEMBL497001 354 None 0 Human Functional pEC50 = 5.9 5.9 - 1
UnclassifiedUnclassified
Guide to Pharmacology 418 3 7 9 -0.9 C1=CC2=C(C(=C1)O)C(=O)C3=C(C2[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C=C(C=C3O)CO 17702579
DB15477 354 None 0 Human Functional pEC50 = 5.9 5.9 - 1
UnclassifiedUnclassified
Guide to Pharmacology 418 3 7 9 -0.9 C1=CC2=C(C(=C1)O)C(=O)C3=C(C2[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C=C(C=C3O)CO 17702579
12499 2269 None 0 Human Functional pEC50 = 6.3 6.3 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 410 4 2 7 1.8 CC1=C2[C@@H]([C@@H]3[C@@H]([C@H](C1)OC(=O)CC4=CC=C(C=C4)O)C(=C)C(=O)O3)C(=CC2=O)CO 36601079
174880 2269 None 0 Human Functional pEC50 = 6.3 6.3 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 410 4 2 7 1.8 CC1=C2[C@@H]([C@@H]3[C@@H]([C@H](C1)OC(=O)CC4=CC=C(C=C4)O)C(=C)C(=O)O3)C(=CC2=O)CO 36601079
12438 471 None 0 Human Functional pEC50 = 7.1 7.1 5 3
UnclassifiedUnclassified
Guide to Pharmacology 341 3 1 6 3.3 COC1=CC=CC2=C3C(=C(C=C21)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)O 15537898
2236 471 None 0 Human Functional pEC50 = 7.1 7.1 5 3
UnclassifiedUnclassified
Guide to Pharmacology 341 3 1 6 3.3 COC1=CC=CC2=C3C(=C(C=C21)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)O 15537898
CHEMBL93353 471 None 0 Human Functional pEC50 = 7.1 7.1 5 3
UnclassifiedUnclassified
Guide to Pharmacology 341 3 1 6 3.3 COC1=CC=CC2=C3C(=C(C=C21)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)O 15537898
12470 1276 None 0 Human Functional pIC50 = 2.3 2.3 3 2
UnclassifiedUnclassified
Guide to Pharmacology 179 2 2 2 0.7 C1CCC(CC1)NS(=O)(=O)O 28919036
7533 1276 None 0 Human Functional pIC50 = 2.3 2.3 3 2
UnclassifiedUnclassified
Guide to Pharmacology 179 2 2 2 0.7 C1CCC(CC1)NS(=O)(=O)O 28919036
CHEMBL1206440 1276 None 0 Human Functional pIC50 = 2.3 2.3 3 2
UnclassifiedUnclassified
Guide to Pharmacology 179 2 2 2 0.7 C1CCC(CC1)NS(=O)(=O)O 28919036
6300 945 None 0 Human Functional pIC50 = 4.1 4.1 - 1
UnclassifiedUnclassified
Guide to Pharmacology 154 5 0 1 3.0 O=CCC(CCC=C(C)C)C 27569025
7794 945 None 0 Human Functional pIC50 = 4.1 4.1 - 1
UnclassifiedUnclassified
Guide to Pharmacology 154 5 0 1 3.0 O=CCC(CCC=C(C)C)C 27569025
12471 106 None 0 Human Functional pIC50 = 4.1 4.1 - 1
UnclassifiedUnclassified
Guide to Pharmacology 114 4 0 1 2.0 CCCC(C)CC=O 27569025
140511 106 None 0 Human Functional pIC50 = 4.1 4.1 - 1
UnclassifiedUnclassified
Guide to Pharmacology 114 4 0 1 2.0 CCCC(C)CC=O 27569025
25099817 1802 None 0 Human Functional pIC50 = 5.0 5.0 -3 3
UnclassifiedUnclassified
Guide to Pharmacology 198 4 1 1 3.3 CC1CCC(C1(C)C)CCCC(=O)O 20537538
9112 1802 None 0 Human Functional pIC50 = 5.0 5.0 -3 3
UnclassifiedUnclassified
Guide to Pharmacology 198 4 1 1 3.3 CC1CCC(C1(C)C)CCCC(=O)O 20537538




Ligands (move mouse cursor over ligand name to see structure) Receptor Activity Chemical information
Sel. page Common
name
GPCRdb
ID
Reference
ligand
Vendors

Species

Assay
Type
Activity
Type
Activity
Relation
Activity
Value
p-value
(-log)
Fold
selectivity
Tested
GPCRs
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI